Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Inhaled Carbon Monoxide on the Effectiveness of Neonatal Pulmonary Hypertension

NCT01818843 is registered in ClinicalTrials.gov with CAN WANG as lead sponsor.

NCT NCT01818843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01818843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Inhaled Carbon Monoxide on the Effectiveness of Neonatal Pulmonary Hypertension
Lead sponsor
CAN WANG
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2012
Completion date
December 31, 2013
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

miscellaneous disorders in the fetus or newborn